14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $23.75 $29.93 Monday, 15th Apr 2024 ARWR stock ended at $24.01. This is 2.79% less than the trading day before Friday, 12th Apr 2024. During the day the stock fluctuated 4.67% from a day low at $23.75 to a day high of $24.86.
90 days $23.75 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2021-06-30 $81.01 $84.31 $81.00 $82.82 639 045
2021-06-29 $86.00 $86.48 $81.47 $81.50 1 101 058
2021-06-28 $89.41 $91.00 $85.93 $86.22 767 316
2021-06-25 $89.34 $90.44 $88.30 $90.32 1 631 668
2021-06-24 $88.69 $90.41 $88.48 $89.51 704 957
2021-06-23 $90.00 $93.66 $87.35 $88.09 1 022 383
2021-06-22 $89.22 $89.63 $87.52 $88.83 723 246
2021-06-21 $85.94 $90.60 $85.81 $89.81 856 472
2021-06-18 $85.03 $86.71 $84.51 $85.64 1 264 630
2021-06-17 $85.44 $86.93 $84.93 $85.98 532 705
2021-06-16 $86.65 $87.36 $83.89 $85.84 622 725
2021-06-15 $88.59 $89.17 $85.72 $86.63 741 494
2021-06-14 $88.00 $89.77 $87.52 $88.41 685 102
2021-06-11 $86.72 $90.64 $86.40 $88.71 1 495 580
2021-06-10 $81.70 $84.41 $80.80 $83.72 691 639
2021-06-09 $81.86 $82.86 $81.10 $81.81 771 978
2021-06-08 $80.71 $81.83 $78.42 $81.09 676 080
2021-06-07 $76.29 $81.52 $76.19 $80.68 881 810
2021-06-04 $72.93 $76.37 $72.76 $76.14 719 776
2021-06-03 $72.37 $72.84 $71.03 $72.52 840 794
2021-06-02 $71.75 $72.33 $71.22 $72.24 1 251 106
2021-06-01 $72.51 $73.51 $71.59 $71.91 897 102
2021-05-28 $73.19 $74.40 $72.36 $72.60 933 919
2021-05-27 $74.06 $74.06 $72.41 $72.77 823 033
2021-05-26 $74.66 $74.66 $72.60 $73.47 418 334
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT